HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dandan Sun Selected Research

Peptides (Polypeptides)

12/2023miR-186-5p targets TGFβR2 to inhibit RAW264.7 cell migration and proliferation during mouse skin wound healing.
1/2023Peptide RL-QN15 promotes wound healing of diabetic foot ulcers through p38 mitogen-activated protein kinase and smad3/miR-4482-3p/vascular endothelial growth factor B axis.
12/2022Scorpion venom peptide HsTx2 suppressed PTZ-induced seizures in mice via the circ_0001293/miR-8114/TGF-β2 axis.
7/2022Zn2+ Cross-Linked Alginate Carrying Hollow Silica Nanoparticles Loaded with RL-QN15 Peptides Provides Promising Treatment for Chronic Skin Wounds.
10/2021Hollow polydopamine nanoparticles loading with peptide RL-QN15: a new pro-regenerative therapeutic agent for skin wounds.
2/2011Structure-function relationship of conotoxin lt14a, a potential analgesic with low cytotoxicity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dandan Sun Research Topics

Disease

28Neoplasms (Cancer)
04/2023 - 02/2011
24Stroke (Strokes)
03/2024 - 03/2006
21Ischemia
01/2020 - 01/2003
18Ischemic Stroke
03/2024 - 04/2014
12Infarction (Infarctions)
08/2023 - 01/2003
12Brain Ischemia (Cerebral Ischemia)
04/2014 - 01/2003
10Glioma (Gliomas)
05/2022 - 02/2014
9Brain Injuries (Brain Injury)
01/2021 - 01/2011
8Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2012
7Inflammation (Inflammations)
08/2023 - 08/2016
7Traumatic Brain Injuries (Traumatic Brain Injury)
01/2021 - 11/2013
6Wounds and Injuries (Trauma)
12/2023 - 03/2017
6Hypertension (High Blood Pressure)
01/2022 - 06/2013
5Hepatocellular Carcinoma (Hepatoma)
04/2024 - 01/2021
5Type 2 Diabetes Mellitus (MODY)
01/2024 - 01/2019
5Neuroinflammatory Diseases
08/2023 - 03/2013
5Gliosis
08/2023 - 01/2018
5Hyperglycemia
06/2023 - 01/2020
5Infections
01/2022 - 01/2012
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 08/2009
5Hypoxia (Hypoxemia)
05/2015 - 03/2007
4Carcinogenesis
01/2024 - 12/2017
4Mitochondrial Diseases (Mitochondrial Disease)
12/2022 - 03/2007
4Coronary Artery Disease (Coronary Atherosclerosis)
12/2021 - 03/2016
3Diabetic Retinopathy (Retinopathy, Diabetic)
04/2024 - 12/2022
3Demyelinating Diseases (Demyelinating Disease)
03/2024 - 11/2018
3Breast Neoplasms (Breast Cancer)
01/2023 - 11/2017
3Epilepsy (Aura)
12/2022 - 03/2016
3Fibrosis (Cirrhosis)
04/2022 - 01/2019
3Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 01/2021
3Myocardial Infarction
12/2021 - 10/2015
3Heart Failure
12/2021 - 01/2020
3Neuralgia (Stump Neuralgia)
01/2021 - 09/2008
3Schizophrenia (Dementia Praecox)
01/2021 - 04/2015
3Diabetes Mellitus
07/2020 - 01/2019
3Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2019 - 03/2006
3Pain (Aches)
03/2015 - 06/2010
3Spinal Cord Injuries (Spinal Cord Injury)
05/2014 - 03/2003
2Body Weight (Weight, Body)
05/2023 - 01/2022
2Atrial Fibrillation
01/2023 - 07/2020
2Diabetic Angiopathies (Diabetic Angiopathy)
01/2023 - 12/2022
2Melanoma (Melanoma, Malignant)
01/2023 - 09/2013
2Seizures (Absence Seizure)
12/2022 - 03/2016
2Colitis
07/2022 - 10/2020

Drug/Important Bio-Agent (IBA)

30Proteins (Proteins, Gene)FDA Link
03/2024 - 03/2006
17Protein Isoforms (Isoforms)IBA
01/2022 - 01/2003
13Phosphotransferases (Kinase)IBA
02/2024 - 09/2007
10Sodium-Potassium-Chloride SymportersIBA
04/2022 - 01/2003
10Bumetanide (Bumex)FDA LinkGeneric
01/2020 - 01/2003
9cariporideIBA
08/2023 - 12/2005
7MicroRNAs (MicroRNA)IBA
01/2023 - 02/2011
7Glucose (Dextrose)FDA LinkGeneric
01/2023 - 12/2003
7Temozolomide (Temodar)FDA LinkGeneric
01/2021 - 01/2012
7Sodium-Hydrogen ExchangersIBA
01/2018 - 09/2007
6Alanine (L-Alanine)FDA Link
01/2024 - 05/2014
6Proline (L-Proline)FDA Link
01/2024 - 05/2014
6Peptides (Polypeptides)IBA
12/2023 - 02/2011
5Lysine (L-Lysine)FDA Link
01/2024 - 02/2014
5ChloridesIBA
01/2023 - 01/2005
5Oxygen (Dioxygen)IBA
11/2022 - 12/2003
5Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2013
5Member 2 Solute Carrier Family 12IBA
01/2022 - 01/2003
5Small Interfering RNA (siRNA)IBA
09/2021 - 03/2007
4salicylhydroxamic acid (SHAM)IBA
01/2023 - 12/2003
4Messenger RNA (mRNA)IBA
01/2023 - 03/2006
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2023 - 01/2021
4Ion Channels (Ion Channel)IBA
01/2021 - 08/2009
4CytokinesIBA
12/2018 - 10/2011
4K Cl- CotransportersIBA
10/2016 - 04/2005
3EnzymesIBA
02/2024 - 03/2016
3Protons (Proton)IBA
01/2024 - 04/2014
3Methylazoxymethanol AcetateIBA
12/2023 - 01/2019
3CyclodextrinsIBA
04/2023 - 09/2021
3Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
01/2022 - 01/2018
3AcidsIBA
02/2021 - 12/2005
3Glutamic Acid (Glutamate)FDA Link
01/2021 - 01/2014
3Neuroprotective AgentsIBA
01/2021 - 02/2012
3Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2021 - 11/2018
3gamma-Aminobutyric Acid (GABA)IBA
01/2019 - 04/2015
3Toll-Like Receptor 4IBA
01/2017 - 03/2016
3Docosahexaenoic AcidsIBA
11/2015 - 02/2012
3Sodium-Calcium ExchangerIBA
10/2015 - 08/2008
3CationsIBA
04/2014 - 06/2003
2FructoseIBA
02/2024 - 12/2022
2Molecular Probes (Molecular Probe)IBA
12/2023 - 12/2022
2Retinaldehyde (Retinal)IBA
06/2023 - 12/2020
2Folic Acid (Vitamin M)FDA LinkGeneric
04/2023 - 09/2021
2AntioxidantsIBA
01/2023 - 05/2017
2LipidsIBA
12/2022 - 01/2020
2Uric Acid (Urate)IBA
12/2022 - 07/2020
2Superoxides (Superoxide)IBA
12/2022 - 11/2013
2Triglycerides (Triacylglycerol)IBA
12/2022 - 07/2020
2Fatty Acids (Saturated Fatty Acids)IBA
07/2022 - 10/2020
2Amino AcidsFDA Link
07/2022 - 01/2020
2Dextran SulfateIBA
07/2022 - 10/2020
2Insulin (Novolin)FDA Link
01/2022 - 12/2017

Therapy/Procedure

25Therapeutics
08/2023 - 06/2010
6Drug Therapy (Chemotherapy)
04/2023 - 01/2017
6Immunotherapy
01/2022 - 01/2018
2Glycemic Control
12/2022 - 01/2022